AZD-0156
CAS No. 1821428-35-6
AZD-0156( AZD0156 | AZD 0156 )
Catalog No. M12809 CAS No. 1821428-35-6
AZD-0156 (AZD0156, AZD 0156) is a potent, highly selective and orally bioavailable ATM inhibitor; exhibits antitumoral activity, both reducing tumor burden and preventing tumors from growing in an immunocompetent allograft mouse model of AML.Solid Tumors,Phase 1 Clinical
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 484 | In Stock |
|
| 500MG | 1035 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZD-0156
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD-0156 (AZD0156, AZD 0156) is a potent, highly selective and orally bioavailable ATM inhibitor; exhibits antitumoral activity, both reducing tumor burden and preventing tumors from growing in an immunocompetent allograft mouse model of AML.Solid Tumors,Phase 1 Clinical
-
DescriptionAZD-0156 (AZD0156, AZD 0156) is a potent, highly selective and orally bioavailable ATM inhibitor; exhibits antitumoral activity, both reducing tumor burden and preventing tumors from growing in an immunocompetent allograft mouse model of AML.Solid Tumors Phase 1 Clinical(In Vitro):AZD0156 inhibits the kinase activity of ATM and ATM-mediated signaling, prevents DNA damage checkpoint activation, and disrupts DNA damage repair, inducs tumor cell apoptosis, and leads to cell death in ATM-overexpressing tumor cells.
-
In VitroAZD0156 inhibits the kinase activity of ATM and ATM-mediated signaling, prevents DNA damage checkpoint activation, and disrupts DNA damage repair, inducs tumor cell apoptosis, and leads to cell death in ATM-overexpressing tumor cells.
-
In Vivo——
-
SynonymsAZD0156 | AZD 0156
-
PathwayCell Cycle/DNA Damage
-
TargetATM/ATR
-
RecptorATM
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number1821428-35-6
-
Formula Weight461.556
-
Molecular FormulaC26H31N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6.2 mg/mL (Need ultrasonic and warming)
-
SMILESO=C(N1C2CCOCC2)N(C)C3=C1C4=CC(C5=CC=C(OCCCN(C)C)N=C5)=CC=C4N=C3
-
Chemical Name2H-Imidazo[4,5-c]quinolin-2-one, 8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Degorce SL, et al. J Med Chem. 2016 Jul 14;59(13):6281-92.
2. Morgado-Palacin I, et al. Sci Signal. 2016 Sep 13;9(445):ra91.
molnova catalog
related products
-
VE822
VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.
-
KU-60019 (b)
KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays.
-
AZD1390
AZD1390 (AZD-1390) is a novel potent, selective, orally available and CNS penetrant ATM inhibitor with IC50 of 0.78 nM.Brain Cancer,Phase 1 Clinical
Cart
sales@molnova.com